Amneal Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Amneal Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Amneal Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Amneal Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15M | 1.4M | 10.01 |
| 2025-06-30 | $13M | 1.6M | 8.09 |
| 2025-03-31 | $15M | 1.8M | 8.38 |
| 2024-12-31 | $13M | 1.7M | 7.92 |
| 2024-09-30 | $181M | 22M | 8.32 |
| 2024-06-30 | $139M | 22M | 6.35 |
| 2024-03-31 | $1.1M | 178k | 6.06 |
| 2023-12-31 | $1.1M | 174k | 6.07 |
| 2023-09-30 | $289k | 68k | 4.22 |
| 2023-06-30 | $37k | 12k | 3.10 |
| 2023-03-31 | $7.3k | 5.2k | 1.39 |
| 2022-12-31 | $38k | 19k | 1.99 |
| 2022-09-30 | $55k | 27k | 2.06 |
| 2022-06-30 | $35k | 11k | 3.14 |
| 2022-03-31 | $52k | 12k | 4.19 |
| 2021-12-31 | $178k | 37k | 4.76 |
| 2021-09-30 | $59k | 11k | 5.36 |
| 2021-06-30 | $103k | 20k | 5.09 |
| 2021-03-31 | $74k | 11k | 6.73 |
| 2020-12-31 | $246k | 54k | 4.55 |
| 2020-09-30 | $165k | 42k | 3.91 |
| 2020-06-30 | $386k | 81k | 4.74 |
| 2020-03-31 | $43k | 12k | 3.48 |
| 2019-12-31 | $27k | 5.5k | 4.91 |
| 2019-09-30 | $22k | 7.6k | 2.88 |
| 2019-06-30 | $167k | 23k | 7.18 |
| 2019-03-31 | $562k | 41k | 13.57 |
| 2018-12-31 | $1.0M | 75k | 13.57 |
| 2018-09-30 | $954k | 50k | 19.11 |
| 2018-06-30 | $932k | 57k | 16.42 |